Sarcoma

Oncology·MeSH: Sarcoma

Prevalence

0.1 / 100K

117 drugs in development·46 companies·30 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
canine osteosarcoma vaccine	ARATANA THERAPEUTICS, INC. (PETX)
eribulin	DR REDDYS LABORATORIES LTD (RDY)
leucovorin calcium preservative free	Mylan II B.V. (MYL)
leucovorin calcium preservative free	Seagen Inc. (SGEN)
tecelra	Adaptimmune Therapeutics PLC (ADAP)

Phase 3(19)

Drug	Company
actinomycin d	GH Research PLC (GHRS)
azenosertib	Zentalis Pharmaceuticals, Inc. (ZNTL)
azenosertib (ZN-c3)	Zentalis Pharmaceuticals, Inc. (ZNTL)
Cabozantinib S-malate	Valneva SE (VALN)
cmb305	IMMUNE DESIGN CORP. (IMDZ)
Dactinomycin	Merus N.V. (MRUS)
Dactinomycin	Filana Therapeutics Inc. (FLNA)
eribulin	INTENSITY THERAPEUTICS, INC. (INTS)
int230-6	INTENSITY THERAPEUTICS, INC. (INTS)
Lurbinectedin	Crinetics Pharmaceuticals, Inc. (CRNX)
pazopanib	INTENSITY THERAPEUTICS, INC. (INTS)
preoperative chemotherapy	GH Research PLC (GHRS)
RP1 (vusolimogene oderparepvec)	Replimune Group, Inc. (REPL)
Single-agent chemotherapy	PTC THERAPEUTICS, INC. (PTCT)
TBI-1301	Filana Therapeutics Inc. (FLNA)
til	GH Research PLC (GHRS)
vincristine	GH Research PLC (GHRS)
Vincristine	Black Diamond Therapeutics, Inc. (BDTX)
Vinorelbine Tartrate	Filana Therapeutics Inc. (FLNA)

Phase 2(30)

Drug	Company
AG-120	AGIOS PHARMACEUTICALS, INC. (AGIO)
Cabozantinib S-malate	Assertio Holdings, Inc. (ASRT)
Combination of MK3475 with Metronomic CP	Design Therapeutics, Inc. (DSGN)
Combination of MK3475 with Metronomic CP and G100	Design Therapeutics, Inc. (DSGN)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
Dacarbazine	PTC THERAPEUTICS, INC. (PTCT)
Elraglusib Injection	ACTUATE THERAPEUTICS, INC. (ACTU)
envafolimab	Tracon Pharmaceuticals, Inc. (TCON)
ifosfamide	Black Diamond Therapeutics, Inc. (BDTX)
Ifosfamide	Filana Therapeutics Inc. (FLNA)
imx-110	Immix Biopharma, Inc. (IMMX)
Inactivated Sinopharm or Sinovac COVID-19 vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
incb059872	Incyte Corp. (INCY)
lete-cel	Adaptimmune Therapeutics PLC (ADAP)
LN-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
mecbotamab vedotin	BioAtla, Inc. (BCAB)
ost-her2	OS Therapies Inc (OSTX)
ozekibart	Inhibrx Biosciences, Inc. (INBX)
Pegfilgrastim	ENANTA PHARMACEUTICALS INC (ENTA)
Pfizer-BioNTech vaccine COVID-19 vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
Pioglitazone Oral Product	Merus N.V. (MRUS)
Regorafenib	Filana Therapeutics Inc. (FLNA)
SARS-CoV-2 mRNA Vaccine ARCT-021	ENANTA PHARMACEUTICALS INC (ENTA)
sotigalimab	Apexigen, Inc. (APGN)
SVN53-67/M57-KLH Peptide Vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
Temozolomide	ELI LILLY & Co (LLY)
temsirolimus	Black Diamond Therapeutics, Inc. (BDTX)
Trabectedin	Merus N.V. (MRUS)
Unesbulin	PTC THERAPEUTICS, INC. (PTCT)
vinorelbine	GH Research PLC (GHRS)

Phase 1(40)

Drug	Company
177lu-pnt6555	POINT Biopharma Global Inc. (PNT)
ADCT-601	ADC Therapeutics SA (ADCT)
adxs-her2	OLD AYALA, INC (AYLA)
ADXS-HER2 (ADXS31-164)	Ayala Pharmaceuticals, Inc. (ADXS)
B7-H3-CAR T Cells	Merus N.V. (MRUS)
B7-H3-CAR T Cells	Filana Therapeutics Inc. (FLNA)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
Dendritic Cell Tumor Fusion Vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
FH FOLR1 ST CAR T-cells	Filana Therapeutics Inc. (FLNA)
Filgrastim	ENANTA PHARMACEUTICALS INC (ENTA)
Filgrastim	PTC THERAPEUTICS, INC. (PTCT)
Filgrastim	Black Diamond Therapeutics, Inc. (BDTX)
Ganitumab	Black Diamond Therapeutics, Inc. (BDTX)
GCAR1	Filana Therapeutics Inc. (FLNA)
HDM201	Novartis AG (NVS)
INBRX-109	PTC THERAPEUTICS, INC. (PTCT)
INBRX-109	Merus N.V. (MRUS)
INBRX-109	IGM Biosciences, Inc. (IGMS)
lb-100	LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
leucovorin	Inhibrx Biosciences, Inc. (INBX)
Leucovorin	PTC THERAPEUTICS, INC. (PTCT)
ln-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
mRNA plus Lysate-loaded Dendritic Cell Vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
NK Cell Infusion	ENANTA PHARMACEUTICALS INC (ENTA)
Pazopanib	Novartis AG (NVS)
Pazopanib	PTC THERAPEUTICS, INC. (PTCT)
PEEL-224	PTC THERAPEUTICS, INC. (PTCT)
PEEL-224	Black Diamond Therapeutics, Inc. (BDTX)
PEEL-224	Structure Therapeutics Inc. (GPCR)
PEEL-224	ENANTA PHARMACEUTICALS INC (ENTA)
Pegfilgrastim	Black Diamond Therapeutics, Inc. (BDTX)
Pegfilgrastim	PTC THERAPEUTICS, INC. (PTCT)
PEGYLATED-INTERFERON ALPHA-2A	ENANTA PHARMACEUTICALS INC (ENTA)
pemetrexed	PTC THERAPEUTICS, INC. (PTCT)
Peposertib	Merus N.V. (MRUS)
Peposertib	Accustem Sciences Inc. (ACUT)
Peripheral Blood Stem Cell Infusion	ENANTA PHARMACEUTICALS INC (ENTA)
Temozolomide	Structure Therapeutics Inc. (GPCR)
trifluridine + tipiracil	Inhibrx Biosciences, Inc. (INBX)
Vincristine	Structure Therapeutics Inc. (GPCR)

Preclinical(6)

Drug	Company
ec17	ENDOCYTE INC (ECYT)
LRRC15 monoclonal antibody	Lantheus Holdings, Inc. (LNTH)
man-dox	NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
ost-tadc	OS Therapies Inc (OSTX)
ost-tadc-a	OS Therapies Inc (OSTX)
sw-3431	SpringWorks Therapeutics, Inc. (SWTX)

Unknown(2)

Drug	Company
AT-014	Ayala Pharmaceuticals, Inc. (ADXS)
Bleomycin Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)

N/A(10)

Drug	Company
Ganitumab	Filana Therapeutics Inc. (FLNA)
Ganitumab	PTC THERAPEUTICS, INC. (PTCT)
Ifosfamide	PTC THERAPEUTICS, INC. (PTCT)
Pazopanib	Black Diamond Therapeutics, Inc. (BDTX)
Pazopanib	Filana Therapeutics Inc. (FLNA)
Polyethylene Glycol	Filana Therapeutics Inc. (FLNA)
Polyethylene Glycol	PTC THERAPEUTICS, INC. (PTCT)
Polyethylene Glycol	Black Diamond Therapeutics, Inc. (BDTX)
Temsirolimus	PTC THERAPEUTICS, INC. (PTCT)
Vincristine	PTC THERAPEUTICS, INC. (PTCT)

Phase 1/Phase 2(2)

Drug	Company
interleukin-2	GH Research PLC (GHRS)
pf-07220060	PFIZER INC (PFE)

Phase 2/Phase 3(1)

Drug	Company
inbrx-109	Inhibrx Biosciences, Inc. (INBX)

Phase 4(2)

Drug	Company
Dactinomycin	ENANTA PHARMACEUTICALS INC (ENTA)
pharmacotherapy with amiodarone 200 mg per day	GH Research PLC (GHRS)

Compare drugs

canine osteosarcoma vaccine vs eribulin canine osteosarcoma vaccine vs leucovorin calcium preservative free canine osteosarcoma vaccine vs tecelra

Frequently asked questions

How many drugs are in development for Sarcoma?

BioSniper tracks 117 drugs in development for Sarcoma across 46 companies.

How many clinical trials target Sarcoma?

There are 30 clinical trials targeting Sarcoma tracked by BioSniper.

What is the prevalence of Sarcoma?

The estimated prevalence of Sarcoma is approximately 0.1 per 100,000 population.

Deep-dive into Sarcoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis